We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$7.33B
AUM Growth
+$1.1B
Cap. Flow
+$510M
Cap. Flow %
6.96%
Top 10 Hldgs %
42.14%
Holding
113
New
29
Increased
17
Reduced
25
Closed
26

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$279M
2
BHI
Baker Hughes
BHI
+$200M
3
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$199M
4
ROC
ROCKWOOD HLDGS INC
ROC
+$180M
5
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$155M

Top Sells

Rank Stock Value
1
THI
TIM HORTONS INC COM, CANADA
THI
+$163M
2
ROST icon
Ross Stores
ROST
+$131M
3
COL
Rockwell Collins
COL
+$126M
4
FWLT
FOSTER WHEELER AG (SWITZERLAND)
FWLT
+$115M
5
BBWI icon
Bath & Body Works
BBWI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 17.8%
2 Consumer Discretionary 12.57%
3 Consumer Staples 10.34%
4 Technology 10.15%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIGR
76
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.91M 0.05%
444
– –
RPRX
77
DELISTED
Repros Therapeutics Inc.
RPRX
$2.99M 0.04%
300,000
-400,000
-57% -$3.41M
TRLA
78
DELISTED
TRULIA INC (DEL)
TRLA
$2.3M 0.03%
+50,000
New +$2.35M
LRMR icon
79
Larimar Therapeutics
LRMR
$434M
$1.85M 0.03%
5,000
– –
STML
80
DELISTED
Stemline Therapeutics, Inc.
STML
$1.62M 0.02%
95,000
– –
EVFM
81
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$935K 0.01%
+1,389
New +$1.05M
COVS
82
DELISTED
Covisint Corporation
COVS
$816K 0.01%
+307,818
New +$882K
HELI
83
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$805K 0.01%
8,333
-30,957
-79% -$4.54M
BABA icon
84
Alibaba
BABA
$286B
– –
-530,800
Closed -$47.2M
BBWI icon
85
Bath & Body Works
BBWI
$3.92B
– –
-1,923,535
Closed -$104M
DLTR icon
86
Dollar Tree
DLTR
$25.3B
– –
-505,000
Closed -$28.3M
EDU icon
87
New Oriental
EDU
$8.88B
– –
-2,363,600
Closed -$54.8M
FATE icon
88
Fate Therapeutics
FATE
$279M
– –
-171,196
Closed -$880K
MEOH icon
89
Methanex
MEOH
$4.65B
– –
-440,000
Closed -$29.4M
OIS icon
90
Oil States International
OIS
$522M
– –
-262,952
Closed -$16.3M
QURE icon
91
uniQure
QURE
$3.36B
– –
-50,000
Closed -$463K
ROST icon
92
Ross Stores
ROST
$76.7B
– –
-3,470,000
Closed -$131M
TMUS icon
93
T-Mobile US
TMUS
$196B
– –
-1,670,000
Closed -$48.2M
TPH
94
DELISTED
Tri Pointe Homes
TPH
– –
-1,701,861
Closed -$22M
EGRX
95
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-100,000
Closed -$1.26M
CLVS
96
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-225,000
Closed -$10.2M
KIN
97
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-175,000
Closed -$1.62M
GWPH
98
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-244,000
Closed -$19.7M
MNK
99
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-600,000
Closed -$54.1M
MNK
100
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-378,250
Closed -$34.1M
1 2 3
4
5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2014 Portfolio in Review

As of Q4 2014, Thomas Steyer held 113 positions worth $7.33B, up 18% from $6.23B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Thomas Steyer deployed $510M of net new capital in Q4 2014, opening 29 new positions and adding to 17 existing holdings. Its largest new stake was Baker Hughes: 3,555,000 shares worth $199M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Cognizant, an estimated $101M trimmed.

  • Thomas Steyer's largest Q4 2014 buy was Baker Hughes: 3,555,000 shares worth $199M.
  • Thomas Steyer added most to Allergan Inc in Q4 2014, an estimated $279M increase.
  • Thomas Steyer's biggest Q4 2014 reduction was Cognizant, cutting an estimated $101M.
  • Thomas Steyer fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $163M.
  • Thomas Steyer's ten largest holdings make up 42% of its $7.33B portfolio in Q4 2014.
  • Thomas Steyer opened 29 new positions and closed 26 in Q4 2014.
  • Thomas Steyer's portfolio value rose 18% quarter-over-quarter to $7.33B.

Based on Farallon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.